The European Medicines Agency (EMA) and the Food and Drug Administration (FDA, USA) have been collaborating for several years on the field of Rare Diseases. But recently, this bond has been reinforced and a new cluster is being set up.
What do you know about the exisiting collaboration projects between EMA and FDA focused on RARE Diseases and Patient engagement?
Find out what is underway at http://bit.ly/2eofon7
Write something about yourself. No need to be fancy, just an overview.